NCT00408109View on ClinicalTrials.gov

Safety Study of Avian Flu Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 4, 2006

Study Completion Date

August 28, 2008

Conditions
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus AOrthomyxoviridaeH5N1 Virus
Interventions
DRUG

VRC-AVIDNA036-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00408109 - Safety Study of Avian Flu Vaccine | Biotech Hunter | Biotech Hunter